KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $65.50 $80.00 Friday, 26th Apr 2024 AXSM stock ended at $71.71. This is 0.266% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.92% from a day low at $69.70 to a day high of $72.43.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Jun 05, 2023 $73.88 $76.50 $73.81 $74.82 473 164
Jun 02, 2023 $73.14 $74.28 $71.81 $74.12 617 514
Jun 01, 2023 $74.16 $74.89 $72.56 $72.76 472 680
May 31, 2023 $70.72 $73.95 $69.45 $73.78 759 970
May 30, 2023 $70.25 $70.17 $68.60 $69.45 747 053
May 26, 2023 $69.85 $70.61 $67.68 $69.80 810 322
May 25, 2023 $68.92 $69.17 $67.07 $68.09 868 667
May 24, 2023 $71.00 $71.04 $68.68 $68.73 994 525
May 23, 2023 $74.83 $75.06 $71.64 $71.82 538 939
May 22, 2023 $75.63 $76.21 $73.56 $74.62 618 007
May 19, 2023 $77.28 $77.32 $74.55 $75.71 595 846
May 18, 2023 $78.51 $79.04 $75.90 $76.87 460 603
May 17, 2023 $77.21 $79.12 $75.61 $78.49 446 199
May 16, 2023 $77.15 $77.23 $74.70 $77.08 440 118
May 15, 2023 $79.37 $80.31 $77.05 $77.77 677 197
May 12, 2023 $78.00 $80.25 $77.55 $79.01 516 698
May 11, 2023 $80.99 $82.20 $77.30 $77.97 798 167
May 10, 2023 $77.06 $80.94 $76.50 $80.22 854 663
May 09, 2023 $77.73 $81.12 $76.27 $76.74 1 131 827
May 08, 2023 $78.00 $82.85 $74.05 $77.73 2 764 092
May 05, 2023 $71.79 $73.98 $70.38 $73.74 959 871
May 04, 2023 $71.87 $71.87 $68.84 $71.15 663 764
May 03, 2023 $71.36 $72.62 $70.46 $71.96 526 836
May 02, 2023 $70.12 $71.96 $70.12 $71.28 490 939
May 01, 2023 $71.69 $72.94 $70.25 $70.77 411 245
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT